Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $43.5000 (-1.24%) ($43.5000 - $44.2600) on Thu. Aug. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.66% (three month average) | RSI | 27 | Latest Price | $43.5000(-1.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.8% a day on average for past five trading days. | Weekly Trend | HALO declines -6.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(40%) IWM(36%) IWO(36%) IFRA(35%) IWN(35%) | Factors Impacting HALO price | HALO will decline at least -1.33% in a week (0% probabilities). VIXM(-14%) UUP(-8%) VXX(-6%) TBT(-5%) GLD(3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.33% (StdDev 2.66%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $34.79(-20.02%) | Resistance Level | $47.87 | 5 Day Moving Average | $44.18(-1.54%) | 10 Day Moving Average | $45.77(-4.96%) | 20 Day Moving Average | $47.87(-9.13%) | To recent high | -16.1% | To recent low | 13% | Market Cap | $5.945b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |